Exploring treatment of inflammatory bowel disease with infliximab in the Middle East and Northern Africa: An analysis of the HARIR observational cohort study

BACKGROUND: In 2017, inflammatory bowel disease, including Crohn’s disease (CD) and ulcerative colitis (UC) affected more than 6.8 million people worldwide, with increased incidence in newly industrialized countries. Although treatment options were previously limited to symptom reduction, current ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Alharbi, Othman, Hamed, Waleed, Salem, Osama, Taylor, Catherine, Besar, Ahmed, Sharaf, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358795/
https://www.ncbi.nlm.nih.gov/pubmed/37313946
http://dx.doi.org/10.4103/sjg.sjg_434_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358795/
https://www.ncbi.nlm.nih.gov/pubmed/37313946
http://dx.doi.org/10.4103/sjg.sjg_434_22

Ejemplares similares